MediPal Holdings Corporation
7459.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥3,671,328,000 | ¥3,558,732,000 | ¥3,360,008,000 | ¥3,290,921,000 |
| % Growth | 3.2% | 5.9% | 2.1% | – |
| Cost of Goods Sold | ¥3,429,083,000 | ¥3,312,077,000 | ¥3,135,703,000 | ¥3,073,476,000 |
| Gross Profit | ¥242,245,000 | ¥246,655,000 | ¥224,305,000 | ¥217,445,000 |
| % Margin | 6.6% | 6.9% | 6.7% | 6.6% |
| R&D Expenses | ¥0 | ¥991,000 | ¥103,000 | ¥108,000 |
| G&A Expenses | ¥0 | ¥164,212,000 | ¥144,338,000 | ¥140,870,000 |
| SG&A Expenses | ¥23,593,000 | ¥184,686,000 | ¥163,143,000 | ¥159,487,000 |
| Sales & Mktg Exp. | ¥23,593,000 | ¥20,474,000 | ¥18,805,000 | ¥18,617,000 |
| Other Operating Expenses | ¥163,041,000 | ¥13,648,000 | ¥12,082,000 | ¥12,223,000 |
| Operating Expenses | ¥186,634,000 | ¥199,325,000 | ¥175,328,000 | ¥171,818,000 |
| Operating Income | ¥55,611,000 | ¥47,331,000 | ¥48,972,000 | ¥45,624,000 |
| % Margin | 1.5% | 1.3% | 1.5% | 1.4% |
| Other Income/Exp. Net | ¥21,123,000 | ¥27,410,000 | ¥21,089,000 | ¥11,660,000 |
| Pre-Tax Income | ¥76,734,000 | ¥74,741,000 | ¥70,061,000 | ¥57,284,000 |
| Tax Expense | ¥25,203,000 | ¥22,973,000 | ¥21,738,000 | ¥18,087,000 |
| Net Income | ¥40,280,000 | ¥41,474,000 | ¥38,806,000 | ¥29,423,000 |
| % Margin | 1.1% | 1.2% | 1.2% | 0.9% |
| EPS | 193.19 | 195.83 | 184.82 | 140.13 |
| % Growth | -1.3% | 6% | 31.9% | – |
| EPS Diluted | 193.19 | 195.83 | 179.12 | 131.41 |
| Weighted Avg Shares Out | 208,491 | 211,784 | 209,962 | 209,962 |
| Weighted Avg Shares Out Dil | 208,491 | 211,784 | 216,346 | 223,123 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥50,000 | ¥29,000 | ¥101,000 | ¥177,000 |
| Interest Expense | ¥7,000 | ¥8,000 | ¥34,000 | ¥16,000 |
| Depreciation & Amortization | ¥18,417,000 | ¥17,982,000 | ¥14,648,000 | ¥14,338,000 |
| EBITDA | ¥95,161,000 | ¥92,731,000 | ¥84,743,000 | ¥71,638,000 |
| % Margin | 2.6% | 2.6% | 2.5% | 2.2% |